Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-7bb8b95d7b-cx56b Total loading time: 0 Render date: 2024-09-18T00:18:13.705Z Has data issue: false hasContentIssue false

14 - Primary Carcinoma of the Pleura and Peritoneum

Published online by Cambridge University Press:  16 March 2018

By
Bonnie Balzer
Edited by
Alberto M. Marchevsky ,
Aliya N. Husain  and
Françoise Galateau-Sallé
Alberto M. Marchevsky
Affiliation:
Cedars Sinai Medical Center, Los Angeles
Aliya N. Husain
Affiliation:
University of Chicago
Françoise Galateau-Sallé
Affiliation:
MESOPATH National Reference Center & Cancer Center Leon Berard
Get access

Summary

A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Chapter
Information
Practical Pathology of Serous Membranes , pp. 190 - 202
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Babolini, B. The pleural form of primary cancer of the lung. Dis Chest. 1956;29(3):314–23.Google ScholarPubMed
Attanoos, RL, Gibbs, AR. Pseudomesotheliomatous carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff Histopathol. 2003;43(5):444–52.Google ScholarPubMed
Koss, MN, Travis, WD, Moran, CA, Hochholzer, L. Pseudomesotheliomatous adenocarcinoma: a reappraisal. Semin Diagn Pathol. 1992;9:117–23.Google ScholarPubMed
Saito, R, Kasajima, A, Taniuchi, S, Fujishima, F, Ishida, K, Nakamura, Y, et al. Case reports of primary pulmonary adenocarcinoma with pleural spread: so-called pseudomesotheliomatous adenocarcinoma Pathol Int. 2012;62(10):709–15.CrossRefGoogle ScholarPubMed
Travis, WD, Travis, LB, Devesa, SS. Lung cancer. Cancer. 1995;5:191–202.3.0.CO;2-Y>CrossRefGoogle Scholar
Devesa, SS, Shaw, GL, Blot, WJ. Changing patterns of lung carcinoma. Cancer Epidemiol Biomarkers Prev. 1991;1:29–34.Google Scholar
Roberts, ME, Neville, E, Berrisford, RG, Antunes, F, Ali, NJ, BTS Pleural Disease Guideline Groups. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65(Suppl 2):ii32–40.CrossRefGoogle ScholarPubMed
Moran, CA, Suster, S. Primary mucoepidermoid carcinoma of the pleura. A clinicopathologic study of two cases. Am J Clin Pathol. 2003;120:381–85.CrossRefGoogle ScholarPubMed
Lin, X, Chi, C, Chen, J, Liu, Y, Li, P, Yang, Y. Primary pleural squamous cell carcinoma misdiagnosed as localized mesothelioma: a case report and review of the literature. J Cardiothorac Surg. 2013;8:50.CrossRefGoogle ScholarPubMed
Harwood, TR, Gracey, DR, Yokoo, H. Pseudomesotheliomatous carcinoma of the lung: a variant of peripheral lung cancer. Am J Clin Pathol. 1976;65(2):159–67.CrossRefGoogle Scholar
Dodson, RF, Hammar, SP. Analysis of asbestos concentration in 20 cases of pseudomesotheliomatous lung cancer. Ultrastruct Pathol. 2015;39(1):13–22.CrossRefGoogle ScholarPubMed
Jagirdar, J. Application of immunohistochemistry to the diagnosis of primary and metastatic carcinoma to the lung. Arch Pathol Lab Med. 2008;132:384–96.CrossRefGoogle Scholar
Pardo, J, Torres, W, Martinez-Peñuela, A, Panizo, A, de Alava, E, García, JL. Pseudomesotheliomatous carcinoma of the lung with a distinct morphology, immunohistochemistry, and comparative genomic hybridization profile. Ann Diagn Pathol. 2007;11(4):241–51.CrossRefGoogle ScholarPubMed
Ordonez, NG. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update. Hum Pathol. 2007;38:1–16.CrossRefGoogle ScholarPubMed
Christensen, BC, Marsit, CJ, Houseman, EA, Godleski, JJ, Longacker, JL, Zheng, S, et al. Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res. 2009;69:6315–21.CrossRefGoogle ScholarPubMed
Ladanyi, M. Implications of P16/CDKN2A deletion in pleural mesotheliomas. Lung Cancer. 2005;49(Suppl 1):S95–98.CrossRefGoogle ScholarPubMed
Lopez-Rios, F, Chuai, S, Flores, R, Shimizu, S, Ohno, T, Wakahara, K, et al. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006;66:2970–79.Google ScholarPubMed
Lee, AY, Raz, DJ, He, B, Jablons, DM. Update on the molecular biology of malignant mesothelioma. Cancer. 2007;109:1454–61.CrossRefGoogle ScholarPubMed
Lee, Y, Miron, A, Drapkin, R, Nucci, MR, Medeiros, F, Saleemuddin, A, et al. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol. 2007;211 (1):26–35.CrossRefGoogle ScholarPubMed
Dubeau, L. The cell of origin of ovarian epithelial tumours. Lancet Oncol. 2008;9(12):1191–97.CrossRefGoogle ScholarPubMed
Nik, NN, Vang, R, Shih, leM, Kurman, RJ. Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma. Ann Rev Pathol. 2014;9:27–45.CrossRefGoogle ScholarPubMed
King, M-C, Marks, J, Mandell, J, New York Breast Cancer Study Group. Breast and Ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science. 2003;302(5645):643–46.CrossRefGoogle ScholarPubMed
Kauff, ND, Satagopan, JM, Robson, ME, Scheuer, L, Hensley, M, Hudis, CA, et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2002:346:1609–15.CrossRefGoogle ScholarPubMed
Jermann, M, Vogt, P, Pestalozzi, BC. Peritoneal carcinoma in a male patient. Oncology. 2003;64(4):468–74.CrossRefGoogle ScholarPubMed
Shmueli, E, Leider-Tredjo, L, Schwartz, I, Aderka, D, Inbar, M. Primary papillary serous carcinoma in the peritoneum in a man. Ann Oncol. 2001;12(4)563–67.CrossRefGoogle ScholarPubMed
Ayhan, A, Kurman, RJ, Yemelyanova, A, Vang, R, Logani, S, Seidman, JD, et al. Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis. Am J Surg Pathol. 2009;33(8):1220–24.CrossRefGoogle ScholarPubMed
Vang, R, Shih, leM, Kurman, R. Ovarian low-grade and high grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol. 2009; 16(5):267–82.CrossRefGoogle ScholarPubMed
Dehari, R, Kurman, RJ, Logani, S, Shih, IeM. The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis. Am J Surg Pathol. 2007;31(7):1007–12.CrossRefGoogle ScholarPubMed
Bloss, JD, Liao, S, Buller, RE, Manetta, A, Berman, ML, McMeekin, S, et al. Extra ovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.CrossRefGoogle Scholar
Singh, N, Gilks, CB, Hirshowitz, L, Wilkinson, N, McCluggage, WG. Adopting a uniform approach to site assignment in tubo-ovarian high-grade serous carcinoma: the time has come. Int J Gynecol Pathol. 2016;35(3):230–37.CrossRefGoogle ScholarPubMed
Soslow, RJ, Han, G, Park, KJ, Garg, K, Olvera, N, Spriggs, DR, et al. Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma. Mod Pathol. 2012;25:625–36.CrossRefGoogle ScholarPubMed
Panagopoulos, I, Thorsen, J, Gorunova, L, Micci, F, Haugom, L, Davidson, B, et al. RNA sequencing identifies fusion of the EWSR1 and YY1 genes in mesothelioma with t(14;22)(q32;q12). Genes Chromosomes Cancer. 2013;52(8):733–40.CrossRefGoogle Scholar
Bhargava, R, Beriwal, S, Dabbs, D. An immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007;127:103–13.CrossRefGoogle ScholarPubMed
Comin, CE, Novelli, L, Cavazza, A, Rotellini, M, Cianchi, F, Messenrini, L. Expression of thrombomodulin, calretinin, cytokeratin 5/6, D2–40 and WT-1 in a series of primary carcinomas of the lung: an immunohistochemical study in comparison with epithelioid pleural mesothelioma. Tumori. 2014;100(5):559–67.Google Scholar
Espinosa, I, Gallardo, A, D'Angelo, E, Mozos, A, Lerma, E, Prat, J. Simultaneous carcinomas of the breast and ovary: utility of Pax-8, WT-1, and GATA3 for distinguishing independent primary tumors from metastases. Int J Gynecol Pathol. 2015;34(3):257–65.CrossRefGoogle ScholarPubMed
Lau, SK, Chu, PF, Weiss, LM. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma. Appl Immunohistochem Mol Morphol. 2006;14:83–87.CrossRefGoogle ScholarPubMed
Laury, AR, Perets, R, Piao, H, Krane, JF, Barletta, JA, French, C, et al. A comprehensive analysis of PAX8 expression in human epithelial tumors. Am J Surg Pathol. 2011;35(6):816–26.CrossRefGoogle ScholarPubMed
Mazziotta, RM, Borczuk, AC, Powerll, CA, Mansukhani, M. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Appl Immunohistochem Mol Morphol. 2005;13:55–60.CrossRefGoogle ScholarPubMed
Miettinen, M, McCue, PA, Sarlomo-Rikala, M, Rys, J, Czapiewski, P, Wazny, K, et al. Gata3: a multispecific but potentially useful marker in surgical pathology: a systematic anlysis of 2500 epithelial and nonepithelial tumors. Am J Surg Pathol. 2014;38(1):13–22.CrossRefGoogle Scholar
Tong, GX, Yu, WM, Beaubier, NT, Weeden, EM, Hamele, B, Mansukhai, MM, et al. Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study. Mod Pathol. 2009;22:1218–27.CrossRefGoogle ScholarPubMed
Nofech-Mozes, S, Khalifa, M, Ismiil, N, Reda, S, Saad, W, Hanna, WM, et al. Immunophenotyping of serous carcinoma of the female genital tract. Mod Pathol. 2008;21:1147–55.CrossRefGoogle ScholarPubMed
Andrici, J, Jung, J, Sheen, A, D’Urso, L, Sioson, L, Pickett, J, et al. Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma. Hum Pathol. 2016;51:9–15.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×